Cargando…

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Multiple myeloma (MM) is an incurable hematologic malignancy with disparities in outcomes noted among racial-ethnic subgroups, likely due to disparities in access to effective treatment modalities. Clinical trials can provide access to evidence-based medicine but representation of minorities on ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ailawadhi, Sikander, Jacobus, Susanna, Sexton, Rachael, Stewart, Alexander K., Dispenzieri, Angela, Hussein, Mohamad A., Zonder, Jeffrey A., Crowley, John, Hoering, Antje, Barlogie, Bart, Orlowski, Robert Z., Rajkumar, S. Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035273/ https://www.ncbi.nlm.nih.gov/pubmed/29980678 http://dx.doi.org/10.1038/s41408-018-0102-7

Ejemplares similares

A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434
por: Srkalovic, Gordan, et al.
Publicado: (2014)

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)
por: Usmani, S., et al.
Publicado: (2022)

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
por: Durie, Brian G. M., et al.
Publicado: (2020)

Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211
por: Usmani, S Z, et al.
Publicado: (2015)

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival
por: Van Ness, Brian, et al.
Publicado: (2008)

End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma
por: Hoering, Antje, et al.
Publicado: (2017)

Global disparities in patients with multiple myeloma: a rapid evidence assessment
por: Mateos, Maria-Victoria, et al.
Publicado: (2023)

RACE AND ETHNICITY DISPARITIES IN SUBJECTIVE COGNITIVE DECLINE
por: Reed, Nia, et al.
Publicado: (2019)

Socioeconomic and race/ethnic disparities in observed park quality
por: Engelberg, Jessa K., et al.
Publicado: (2016)

Disparities in pedestrian streetscape environments by income and race/ethnicity
por: Thornton, Christina M., et al.
Publicado: (2016)

Outcomes of COVID-19: disparities in obesity and by ethnicity/race
por: Townsend, Matthew J., et al.
Publicado: (2020)

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma
por: Heuck, C J, et al.
Publicado: (2014)

Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
por: Ailawadhi, Sikander, et al.
Publicado: (2018)

Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
por: Parrondo, Ricardo D., et al.
Publicado: (2022)

Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study.
por: Schwartz, Brian S, et al.
Publicado: (2004)

Disparities by Race and Ethnicity in Cancer Survivor Stories Available on the Web
por: Eddens, Katherine S, et al.
Publicado: (2009)

New race and ethnicity standards: elucidating health disparities in diabetes
por: Katzmarzyk, Peter T, et al.
Publicado: (2012)

Pulling at the heart: COVID-19, race/ethnicity and ongoing disparities
por: Chin-Hong, Peter, et al.
Publicado: (2020)

Examining Wage Disparities by Race and Ethnicity of Health Care Workers
por: Frogner, Bianca K., et al.
Publicado: (2021)

Disparities in smoking during pregnancy by sexual orientation and race-ethnicity
por: Hartnett, Caroline Sten, et al.
Publicado: (2021)

The Importance of Measuring and Analyzing Disparities in Vaccine Hesitancy by Race and Ethnicity
por: Reingle Gonzalez, Jennifer Marie, et al.
Publicado: (2021)

Residential and Race/Ethnicity Disparities in Heat Vulnerability in the United States
por: Manware, Mitchell, et al.
Publicado: (2022)

Disparities in COVID-19 Hospitalization at the Intersection of Race and Ethnicity and Income
por: Whittington, Blair J., et al.
Publicado: (2023)

Discrepancies in Race and Ethnicity Documentation: a Potential Barrier in Identifying Racial and Ethnic Disparities
por: Magaña López, M., et al.
Publicado: (2016)

Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma
por: Khan, R, et al.
Publicado: (2015)

Sleep health disparity: the putative role of race, ethnicity and socioeconomic status
por: Jehan, Shazia, et al.
Publicado: (2018)

Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities
por: Staron, Andrew, et al.
Publicado: (2020)

Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity
por: Reitsma, Marissa B., et al.
Publicado: (2021)

The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology
por: Hirko, Kelly A., et al.
Publicado: (2022)

Disparities in Wait Times for Care Among US Veterans by Race and Ethnicity
por: Gurewich, Deborah, et al.
Publicado: (2023)

US Cigarette Smoking Disparities by Race and Ethnicity — Keep Going and Going!
por: Arrazola, René A., et al.
Publicado: (2023)

Emergency Department Pediatric Readiness and Disparities in Mortality Based on Race and Ethnicity
por: Jenkins, Peter C., et al.
Publicado: (2023)

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups
por: Ailawadhi, S, et al.
Publicado: (2014)

Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy
por: Longcor, Jarrod, et al.
Publicado: (2022)

An Evaluation of Gene Set Analysis for Biomarker Discovery with Applications to Myeloma Research
por: Qu, Pingping, et al.
Publicado: (2017)

Toward a Demographic Understanding of Incarceration Disparities: Race, Ethnicity, and Age Structure
por: Vogel, Matt, et al.
Publicado: (2015)

The Intersection of Rural Residence and Minority Race/Ethnicity in Cancer Disparities in the United States
por: Zahnd, Whitney E., et al.
Publicado: (2021)

Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity
por: Cullen, Mark R., et al.
Publicado: (2022)

Disparities in SARS-CoV-2 Positivity Rates: Associations with Race and Ethnicity
por: Kaufman, Harvey W., et al.
Publicado: (2021)

Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study
por: Wright, Clinton B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1iqa1eink0ouldq62bjuthc6m6